Nautilus Biotechnology Inc Financial Flexibility Index
Nautilus Biotechnology Inc financial flexibility index. Nautilus Biotechnology Inc (NAUT) has a Financial Flexibility Index of -0.41x as of June 2026. Free cash flow of $-13.27 Million (operating CF $-13.73 Million minus capex $454.00K) represents 0% of total liabilities ($32.46 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Nautilus Biotechnology Inc (2018–2025)
Financial flexibility index of Nautilus Biotechnology Inc from 2018 to 2025. Historical Financial Flexibility Index trend for Nautilus Biotechnology Inc across 8 annual periods. Check how high is Nautilus Biotechnology Inc's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Nautilus Biotechnology Inc Financial Flexibility Index by Year (2018–2025)
Nautilus Biotechnology Inc financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Nautilus Biotechnology Inc. For the full cash flow conversion analysis, see cash flow conversion of Nautilus Biotechnology Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.45x | $-49.42 Million | $-50.70 Million | $34.14 Million | ▲ +13.7% |
| 2024 | -1.68x | $-57.02 Million | $-59.15 Million | $34.01 Million | ▼ -36.8% |
| 2023 | -1.23x | $-49.27 Million | $-51.71 Million | $40.21 Million | ▲ +1.0% |
| 2022 | -1.24x | $-43.48 Million | $-45.81 Million | $35.13 Million | ▼ -16.8% |
| 2021 | -1.06x | $-36.97 Million | $-39.24 Million | $34.87 Million | ▼ -830.3% |
| 2020 | -0.11x | $-13.07 Million | $-14.00 Million | $114.73 Million | ▲ +99.4% |
| 2019 | -17.83x | $-8.74 Million | $-9.66 Million | $490.00K | ▼ -953.6% |
| 2018 | -1.69x | $-238.30 Million | $-238.30 Million | $140.82 Million | — |